TAG / LYKOS THERAPEUTICS

RESULTS

MENTAL HEALTH

FDA Rejects Ecstasy for Psychiatric Use, Prompting Drugmaker to Lay Off 75% of Staff

Almost 100 percent of trial participants reported adverse events using this dangerous hallucinogen.